Interestingly, significant associations between insulin receptor (INSR), insulin-like growth factor 1 (IGF1), insulin-like growth factor-binding protein 3 (IGFBP3), and visfatin (NAMPT) gene polymorphisms, and the risk of NAFLD have been discovered4-7. This evidence concerns the gene NAMPT and metabolic dysfunction-associated steatotic liver disease.